DOLASETRON MESYLATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1997)
Entry Type: Small molecule
Molecule Category: Salt
UNII: U3C8E5BWKR
Parent Compound: DOLASETRON

Structure
InChI Key QTFFGPOXNNGTGZ-LIFGOUTFSA-N
Smile CS(=O)(=O)O.O.O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12
InChI
InChI=1S/C19H20N2O3.CH4O3S.H2O/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17;1-5(2,3)4;/h1-4,9,11-14,20H,5-8,10H2;1H3,(H,2,3,4);1H2/t11-,12-,13+,14+;;

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H26N2O7S
Molecular Weight 438.5
AlogP 2.52
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 2.0
Polar Surface Area 62.4
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 24.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Serotonin 3a (5-HT3a) receptor antagonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Postoperative Nausea and Vomiting 4 D020250 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Cardiac disorders
35.0
Investigations
20.0
Nervous system disorders
12.5
Vascular disorders
10.0
Gastrointestinal disorders
7.5
Injury, poisoning and procedural complications
5.0
Pregnancy, puerperium and perinatal conditions
5.0
Respiratory, thoracic and mediastinal disorders
5.0

Cross References

Resources Reference
ChEMBL CHEMBL2368924
FDA SRS U3C8E5BWKR
CONTENTS